We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.65
Bid: 3.60
Ask: 3.70
Change: -0.10 (-2.67%)
Spread: 0.10 (2.778%)
Open: 3.75
High: 3.75
Low: 3.65
Prev. Close: 3.75
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index

Mon, 04th Dec 2023 16:56

(Alliance News) - Stock prices in London closed lower on Monday, with miners and oil firms holding down the FTSE 100 index.

The FTSE 100 index closed down 16.39 points, 0.2%, at 7,512.96. The FTSE 250 ended down 47.40 points, 0.3%, at 18,361.25, and the AIM All-Share closed down 1.05 points, or 0.2%, at 715.24.

The Cboe UK 100 ended down 0.3% at 749.31 and the Cboe UK 250 closed down 0.3% at 15,878.49. However, the Cboe Small Companies ended up 0.4% at 13,413.09.

In European equities on Monday, the CAC 40 in Paris ended down 0.2%, while the DAX 40 in Frankfurt ended up marginally.

Investors this week will be carefully eyeing the outlook for US interest rates. The latest nonfarm payrolls report is on Friday and the precursor ADP reading on Wednesday.

Fed Chair Jerome Powell on Friday said it is still "premature" to speculate on when the US central bank will start cutting interest rates.

However, on Monday, gold prices hit an all-time high and became the subject of headlines around interest rates.

The yellow metal hit an intraday high on USD2,134 an ounce during the morning session on Monday, but then retreated amid questions around US monetary policy trajectory. Gold was quoted at USD2,025.87 an ounce at the London equities close Monday, down against USD2,055.14 at the close on Friday.

"The precious metal has been driven higher by renewed violence in the Middle East, a weaker US dollar and falling government bond yields. Investors often put money into gold where there are geopolitical tensions as it is considered to be a safe-haven asset. The weaker dollar can also make gold more affordable for non-US buyers," explained AJ Bell's Mould.

"Investors increasingly believe the US central bank will start to cut interest rates next year and that could put further pressure on the dollar."

The pound was quoted at USD1.2620 at the London equities close Monday, down compared to USD1.2659 at the close on Friday.

The euro stood at USD1.0817 at the European equities close Monday, lower against USD1.0859 at the same time on Friday. Against the yen, the greenback faded to JPY147.02 from JPY147.37.

Stocks in New York were lower at the London equities close, with the DJIA down 0.4%, the S&P 500 index down 0.9%, and the Nasdaq Composite down 1.6%.

In the FTSE 100, miners closed down at the bottom of the index.

Anglo American was the worst amongst the losers, down 3.7%. Meanwhile, Glencore, Rio Tinto and Antofagasta were down 3.1%, 2.7% and 2.6% respectively.

Oil firms Shell and BP also tracked lower on lower oil prices. They were down 1.2% and 1.4%, respectively.

Brent oil was quoted at USD78.53 a barrel at the London equities close Monday, down from USD80.73 late Friday.

Rolls-Royce closed up 3.1% at the top of the index.

Rolls-Royce has "far higher" customer advances from its long-term service agreements on its balance sheet than it had previously disclosed, according to JPMorgan.

This prompted the investment bank to upgrade its outlook for the London-based jet engine maker. Since April 2018, JPMorgan rated Rolls-Royce shares at either 'underweight' or 'neutral'. It now rates the firm at 'overweight.'

In the FTSE 250 index, 888 shot up 19%, after it rebuffed a GBP700 million takeover bid from gambling software provider Playtech.

Citing City sources, the Sunday Times said Playtech had made an indicative approach in July, pitching an offer at 156 pence per share. Bookmaker 888 believed this undervalued the firm. The Gibraltar-based betting operator, which owns the William Hill and Mr Green brands.

Playtech shares rose 1.1%.

Amongst London's small caps, Petrofac jumped 22%, despite predicting a free cash flow miss.

The provider of services to the energy industry also said it is mulling a "range of strategic and financial options" to bolster its coffers.

"Management has been making progress in organic actions to unwind working capital, collect receipts on ongoing and new contracts and to unlock long-outstanding commercial settlements. In addition, management is considering the sale of non-core assets, and is actively engaged in discussions with financial investors to take a non-controlling position in certain other components of the business portfolio," it added.

On AIM, Cornerstone FS shares rocketed 35%.

The cloud-based payment services provider predicts 2023 adjusted earnings before interest, tax, depreciation and amortisation "materially above current market expectations". For 2022, it had reported an adjusted Ebitda loss of GBP869,319 of 2022, narrowed from GBP1.3 million in 2021.

On the other hand, Fusion Antibodies lost 23%. It reported a widened loss and reduced revenue for its latest half year, but said its growth prospects are "increasingly positive".

In Tuesday's UK corporate calendar, there are half year results from Ashtead, as well as first quarter results from Ferguson.

On the economic calendar, a slew of services purchasing managers' index releases are out for China, the EU, Germany, Japan, the UK and the US.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
15 Apr 2024 13:29

Fusion Antibodies inks commercial contract for OptiPhage library

(Alliance News) - Fusion Antibodies PLC on Monday said that it has signed a commercial contract to develop an OptiPhage library for a non-human antibody species.

Read more
27 Feb 2024 14:18

TRADING UPDATES: Sondrel wins USD23 million contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Feb 2024 13:15

Fusion Antibodies gets first order under new services agreement

(Sharecast News) - Fusion Antibodies announced the receipt of its first purchase order under a master services agreement on Tuesday, which it agreed with a prominent diagnostics company on 14 February.

Read more
14 Feb 2024 12:52

Fusion Antibodies raises £1.38m as it seeks new customers

(Sharecast News) - Pre-clinical antibody specialist Fusion Antibodies announced a conditional fundraising of £1.38m before expenses on Wednesday, to help it target mo re industry conferences and customers and generate further supporting data.

Read more
14 Feb 2024 11:27

IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Conditionally raises GBP1.4 million before expenses via placing of 34.4 million shares at 4 pence each. The issue price represents a discount of 5.9% to Fusion's closing mid-market share price on Tuesday. Further, it intends to issue 1.5 million new shares to certain directors in lieu of or in satisfaction of salary and fees due to them and which shall be issued immediately following publication of its announcement. Also intends to grant a total of up to 3.8 million new share options to staff and senior management.

Read more
6 Feb 2024 11:48

Fusion Antibodies strikes follow-on research and development project

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has won a follow-on project under a collaborative research and development agreement with an unnamed "US-based biotechnology company".

Read more
6 Feb 2024 10:05

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
1 Feb 2024 16:27

Fusion Antibodies confirms £0.28m tax credit

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax credit from HMRC on Thursday.

Read more
1 Feb 2024 12:00

Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform

(Alliance News) - Fusion Antibodies PLC on Thursday announced the receipt of a research & development tax credit from UK HM Revenue & Customs for work performed on the development of its OptiMAL platform and other projects in bioinformatics.

Read more
4 Dec 2023 12:01

Fusion Antibodies revenue falls, losses widen in first half

(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenue of £0.54m on Monday, down from £1.9m a year earlier.

Read more
4 Dec 2023 10:23

AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
4 Dec 2023 10:22

Fusion Antibodies shares fall with revenue despite "positive" outlook

(Alliance News) - Fusion Antibodies PLC on Monday reported a widened loss and reduced revenue for its latest half year, but said its growth prospects are "increasingly positive".

Read more
28 Nov 2023 12:09

Fusion Antibodies shares up on deal with US National Cancer Institute

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has signed a collaboration agreement with the US National Cancer Institute to use its OptiMAL product to discover novel antibodies to treat certain targets.

Read more
28 Nov 2023 10:33

AIM WINNERS & LOSERS: Totally swings to half-year loss on NHS blow

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.